Evidence map›Paper›PMID 36778432›Full record

ArticlebioRxiv : the preprint server for biology2023

Frequency variation and dose modification of benznidazole administration for the treatment of

Juan M Bustamante, Brooke E White, Gregory K Wilkerson, Carolyn L Hodo, Lisa D Auckland, Wei Wang, Stephanie McCain, Sarah A Hamer, Ashley B Saunders, Rick L Tarleton

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Juan M BustamanteCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
Brooke E WhiteCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
Gregory K WilkersonMD Anderson Cancer Center, Michale E. Keeling Center for Comparative Medicine and Research, Bastrop, Texas, USA.
Carolyn L HodoDepartment of Veterinary Integrative Biosciences, School of Veterinary Medicine and Biomedical Research, Texas A&M University, College Station, Texas, USA.
Lisa D AucklandDepartment of Veterinary Integrative Biosciences, School of Veterinary Medicine and Biomedical Research, Texas A&M University, College Station, Texas, USA.
Wei WangCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
Stephanie McCainBirmingham Zoo, Birmingham, Alabama.
Sarah A HamerDepartment of Veterinary Integrative Biosciences, School of Veterinary Medicine and Biomedical Research, Texas A&M University, College Station, Texas, USA.
Ashley B SaundersDepartment of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
Rick L TarletonCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA.
Texas A&M University · USUniversity of Georgia · USThe University of Texas MD Anderson Cancer Center · US

Funding

UT Southwestern Center for Translational MedicineUL1TR003163 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2021 to 2025
$39.3M
Multiplex treatment outcomes test for Chagas diseaseR01AI125738 · NIAID · UNIVERSITY OF GEORGIA · PI TARLETON, RICK L · 2016 to 2020
$5.2M
Trypanosoma cruzi dormancy and its implications for therapeutic treatmentR01AI151148 · NIAID · UNIVERSITY OF GEORGIA · PI TARLETON, RICK L · 2020 to 2024
$2.4M
A more effective drug treatment regimen for Trypanosoma cruzi infectionR21AI142469 · NIAID · UNIVERSITY OF GEORGIA · PI BUSTAMANTE, JUAN, TARLETON, RICK L · 2019 to 2020
$414k
NCATS NIH HHS UL1 TR003163NIAID NIH HHS R01 AI125738NIAID NIH HHS R01 AI151148NIAID NIH HHS R21 AI142469
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36778432
PMCPMC9915573
OpenAlexW4318939022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.